PRLD — PRELUDE THERAPEUTICS INC COM

Ownership history in EverSource Wealth Advisors, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which EverSource Wealth Advisors, LLC reported a position in PRELUDE THERAPEUTICS INC COM (PRLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 89 -59 -39.9% 0.00% $128 $1.44
2025 Q2 ADDED 148 +139 +1544.4% 0.00% $120 $0.81
2025 Q1 INITIATED 9 — — 0.00% $7 $0.77
% of Fund (quarterly)    PRLD price (monthly, adj. close)

Other funds also holding PRLD

As of 2025 Q4 — sorted by position size

ORBIMED ADVISORS LLC 3Y 7Y 0.65% BAKER BROS. ADVISORS LP 3Y 7Y 0.17% Kynam Capital Management, LP 3Y 0.15% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 0.07% XTX Topco Ltd 3Y 0.0% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% TWO SIGMA INVESTMENTS, LP 3Y 7Y 0.0% ACADIAN ASSET MANAGEMENT LLC 3Y 7Y 0.0% CALDWELL SUTTER CAPITAL, INC. 3Y 0.0% OMERS ADMINISTRATION Corp 3Y 7Y 0.0%
← Back to EverSource Wealth Advisors, LLC Holdings